Well they can't see the outcomes of the Lavender study results given double blind placebo etc....
BUT they can see the ongoing open label Lilac and Lilac II studies and the results they are having on patients.. So you have to wonder what they are seeing?
DYOR. Not investment advice.
NEU Price at posting:
$2.03 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)